ProfileGDS4718 / 221796_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 34% 49% 37% 29% 41% 23% 34% 47% 45% 43% 43% 68% 24% 29% 30% 62% 58% 23% 26% 47% 69% 55% 43% 65% 67% 21% 50% 17% 40% 70% 34% 20% 53% 43% 42% 30% 34% 40% 71% 58% 63% 20% 25% 23% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.703734
GSM549102patient 115, normal, homogenized [OPG study]5.5005849
GSM549104patient 119, normal, homogenized [OPG study]4.8619537
GSM549108patient 138, normal, homogenized [OPG study]4.5521329
GSM549119patient 077, normal, homogenized [OPG study]5.0466641
GSM549133patient 032, cancer, homogenized [OPG study]4.1959223
GSM549139patient 042, cancer, homogenized [OPG study]4.7115434
GSM549099patient 107, normal, homogenized [OPG study]5.375347
GSM549109patient 139, normal, homogenized [OPG study]5.258745
GSM549110patient 046, normal, homogenized [OPG study]5.1279743
GSM549114patient 063, normal, homogenized [OPG study]5.1034943
GSM549122patient 082, normal, homogenized [OPG study]6.7199868
GSM549134patient 033, cancer, homogenized [OPG study]4.3097124
GSM549136patient 036, cancer, homogenized [OPG study]4.4359729
GSM549140patient 044, cancer, homogenized [OPG study]4.5070830
GSM549111patient 047, normal, homogenized [OPG study]6.3019462
GSM549113patient 057, normal, homogenized [OPG study]5.9590958
GSM549132patient 031, cancer, homogenized [OPG study]4.2394723
GSM549137patient 038, cancer, homogenized [OPG study]4.3759626
GSM549142patient 047, cancer, homogenized [OPG study]5.4563547
GSM549100patient 110, normal, homogenized [OPG study]6.7606369
GSM549107patient 135, normal, homogenized [OPG study]5.7726455
GSM549115patient 068, normal, homogenized [OPG study]5.0609843
GSM549116patient 072, normal, homogenized [OPG study]6.5165
GSM549120patient 078, normal, homogenized [OPG study]6.6426767
GSM549131patient 030, cancer, homogenized [OPG study]4.1460421
GSM549118patient 074, normal, homogenized [OPG study]5.4850550
GSM549129patient 027, cancer, homogenized [OPG study]4.0556117
GSM549123patient 088, normal, homogenized [OPG study]4.9693540
GSM549124patient 006, cancer, homogenized [OPG study]6.835470
GSM549126patient 015, cancer, homogenized [OPG study]4.6896534
GSM549128patient 025, cancer, homogenized [OPG study]4.1337720
GSM549103patient 117, normal, homogenized [OPG study]5.7252753
GSM549117patient 073, normal, homogenized [OPG study]5.0854543
GSM549138patient 041, cancer, homogenized [OPG study]5.0665242
GSM549141patient 045, cancer, homogenized [OPG study]4.4746130
GSM549130patient 028, cancer, homogenized [OPG study]4.7450334
GSM549101patient 111, normal, homogenized [OPG study]5.0481840
GSM549105patient 128, normal, homogenized [OPG study]6.9832571
GSM549106patient 134, normal, homogenized [OPG study]5.9853958
GSM549112patient 048, normal, homogenized [OPG study]6.3305263
GSM549125patient 011, cancer, homogenized [OPG study]4.1655820
GSM549127patient 024, cancer, homogenized [OPG study]4.3068225
GSM549135patient 035, cancer, homogenized [OPG study]4.2115923